Furagene Biopharmaceuticals “We’re the No 1 Global Biotech Company that Operates a Pragmatic Low Cost Model that Brings Quality Affordable Therapeutics to Millions” Furagene Biopharmaceuticals Ltd is an integrated biotechnology company established in 2011 to carryout and facilitate biologics discovery, research & development (R & D) with a mission of widening access to safe affordable efficacious biologics based therapeutics. The company’s focus is development of novel biologics and biosimilars in three disease areas- oncology, immunological disorders and infectious diseases. The company is also engaged in the provision of pharma/life science consulting services in the areas of clinical trial medical services, regulatory affairs consulting, pharmaceutical market intelligence, specialist market entry services for China, UK/Europe and East Africa, and pharmacovigilance. The company is fully recognized as SME by the European Medicines Agency (EMEA) and as such enjoys all the benefits of European SMEs. We also have expertise in project proposal development and consortium building for several UK and European research funding initiatives such as FP7 where we have acted as experts for cancer research calls. In the past we have as part of our integrated services provided market entry services to UK pharma/biotechs finding them potential partners and IPR customers in China. Using our specialist expertise, experience and established contacts since our launch we operated on ground in China advising and facilitating generic manufacturers in Jiangsu province to meet cGMP standards necessary for obtaining Marketing Authorizations from the European Medicines Agency (EMEA). In collaboration with local government trade officials in China, Furagene hosted and facilitated several workshops introducing EMEA generics licensing procedures to pharma stake holders in Jiangsu province. Currently deploying our Pragmatic Low Cost Model For Drug Development we are offering Clinical Trial Medical Services for human medicines and medical devices. Our CT operations are based in a low cost EU country where our clinical professionals have trial experience in oncology, neurology, psychiatry, dermatology and cardiology. All our sites are located in large well equipped hospitals and polyclinics. Utilizing state of the art EDC systems we enable you pay virtual visits to our sites to keep track on progress.